Literature DB >> 5798432

Immunotherapy of malignant disease.

S H Nadler, G E Moore.   

Abstract

Entities:  

Mesh：

Year:  1969        PMID： 5798432     DOI： 10.1001/archsurg.1969.01340150084016

Source DB:  PubMed          Journal:  Arch Surg        ISSN： 0004-0010


× No keyword cloud information.
  12 in total

Review 1.  The role of immunotherapy in the management of patients with malignant melanoma.

Authors:  J E Goodnight; D L Morton
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

2.  Immunotherapy for the patient with cancer.

Authors:  L J Humphrey; W R Jewell; D R Murray; W O Griffen
Journal:  Ann Surg       Date:  1971-01       Impact factor: 12.969

3.  Cancer immunity--hypothesis and clinical trial of lymphocytotherapy for malignant diseases.

Authors:  G E Moore; R E Gerner
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969

4.  Critical analysis of treatment of stage II and stage III melanoma patients with immunotherapy.

Authors:  W R Jewell; J H Thomas; J M Sterchi; P A Morse; L J Humphrey
Journal:  Ann Surg       Date:  1976-05       Impact factor: 12.969

5.  Anti-tumour immunity by normal allogeneic blood transfusion in rat.

Authors:  T Oikawa; M Hosokawa; M Imamura; F Sendo; M Nakayama
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

Review 6.  The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program.

Authors:  James M Balwit; Patrick Hwu; Walter J Urba; Francesco M Marincola
Journal:  J Transl Med       Date:  2011-01-31       Impact factor: 5.531

7.  Virulence of six strains of Mycobacterium bovis (BCG) in mice.

Authors:  N A Sher; S D Chaparas; J Pearson; M Chirigos
Journal:  Infect Immun       Date:  1973-11       Impact factor: 3.441

Review 8.  Tumour immunology and the gut.

Authors:  K C Calman
Journal:  Gut       Date:  1975-06       Impact factor: 23.059

9.  The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cells.

Authors:  Heather J Symons; Moshe Y Levy; Jie Wang; Xiaotao Zhou; Gang Zhou; Sarah E Cohen; Leo Luznik; Hyam I Levitsky; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-05       Impact factor: 5.742

10.  Identity of rearranged LINE/c-MYC junction sequences specific for the canine transmissible venereal tumor.

Authors:  E N Amariglio; I Hakim; F Brok-Simoni; Z Grossman; N Katzir; A Harmelin; B Ramot; G Rechavi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 12.779
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.